Valuation: QuidelOrtho Corporation

Market Cap 1.2B 1.05B 971M 893M 1.69B 116B 1.72B 11.6B 4.55B 56.64B 4.52B 4.42B 195B P/E 2026 *
-11x
P/E 2027 * -110x
Enterprise Value 3.57B 3.12B 2.88B 2.65B 5.02B 344B 5.11B 34.41B 13.5B 168B 13.42B 13.12B 579B EV / Sales 2026 *
1.32x
EV / Sales 2027 * 1.25x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day+3.23%
1 week+5.68%
Current month+4.08%
1 month+25.12%
3 months+4.23%
6 months-48.47%
Current year-36.17%
1 week 16.87
Extreme 16.87
18.63
1 month 11.84
Extreme 11.84
19.8
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
89.11
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
06-30Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
06-24Free

Director

19,599 0.0289%
06-24Free

Director

15,532 0.0229%
Change 5-day change 1-year change 3-year change Capi.($)
+3.23%+5.68%-34.78%-78.07% 1.2B
-1.04%+12.30%+17.25%-19.60% 17.72B
+6.00%+4.78%+19.69%+102.41% 1.64B
-0.83%-6.41%-36.21%+15.16% 1.03B
+3.25%+7.14%-25.93%-51.63% 638M
+0.78%+1.80%-38.30%-55.23% 558M
+2.08%+0.28%+39.59%-52.82% 445M
+2.10%+1.77%-53.71%-58.46% 378M
+0.74%+2.58%-25.03%-27.13% 333M
-1.35%+2.16%+23.85%+4.95% 309M
Average +1.57%+2.32%-11.36%-22.04% 2.43B
Weighted average by Cap. -0.01%+6.30%+8.95%-15.46%

Financials

2026 *2027 *
Net sales 2.71B 2.37B 2.19B 2.01B 3.81B 261B 3.87B 26.1B 10.24B 127B 10.18B 9.95B 439B 2.8B 2.45B 2.26B 2.08B 3.93B 269B 4B 26.95B 10.57B 132B 10.51B 10.28B 454B
Net income -156M -136M -126M -116M -219M -15B -223M -1.5B -589M -7.33B -585M -572M -25.26B -81.93M -71.63M -66.08M -60.75M -115M -7.88B -117M -789M -310M -3.85B -308M -301M -13.28B
Net Debt 2.37B 2.07B 1.91B 1.76B 3.33B 228B 3.38B 22.81B 8.95B 111B 8.9B 8.7B 384B 2.3B 2.01B 1.85B 1.7B 3.23B 221B 3.28B 22.13B 8.68B 108B 8.63B 8.44B 373B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-15 US$18.23 +3.23% 1,346,921
26-07-14 US$17.66 -1.29% 784,679
26-07-13 US$17.89 -2.08% 1,123,060
26-07-10 US$18.27 +4.76% 1,278,522
26-07-09 US$17.44 +1.10% 1,074,513
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
17.66USD
Average target price
20.50USD
Spread / Average Target
+16.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock